CP
YCBD.PRA

Camelot Portfolios’s cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock YCBD.PRA Stock Holding History

Camelot Portfolios’s Portfolio YCBD.PRA Stock Details YCBD.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,000
Closed -$1.24K – 593
2024
Q2 		$1.24K Buy
+2,000
New +$1.36K ﹤0.01% 551
2022
Q4 		– Sell
-28,500
Closed -$99K – 202
2022
Q3 		$99K Hold
28,500
– – 0.09% 154
2022
Q2 		$103K Buy
28,500
+7,500
+36% +$32.9K 0.06% 205
2022
Q1 		$116K Buy
+21,000
New +$112K 0.06% 224

Other funds holding YCBD.PRA

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
CD
Chapin Davis Baltimore, Maryland $569M AUM 145.59% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
AA
Alesco Advisors Pittsford, New York $4.36B AUM 19.15% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Camelot Portfolios's YCBD.PRA Position: Q3 2024 in Review

Camelot Portfolios sold out of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) in Q3 2024, closing a stake of 2,000 shares — an estimated $1.24K sold.

Camelot Portfolios first reported a position in YCBD.PRA in Q1 2022 and held it in 4 quarters. The position peaked at $116K in Q1 2022. 8 funds tracked by Wall St. Rank hold YCBD.PRA as of Q3 2024.

  • Camelot Portfolios reported no remaining cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position as of Q3 2024 after selling out during the quarter.
  • Camelot Portfolios sold 2,000 cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock shares in Q3 2024, an estimated $1.24K.
  • Camelot Portfolios first reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in Q1 2022 and held it in 4 quarters.
  • Camelot Portfolios's cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock position peaked at $116K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock as of Q3 2024.

Based on Camelot Portfolios's 13F filing for Q3 2024, filed 12 Nov 2024.